Skip to main content

CT Imaging Characteristics of Hepatocellular Carcinoma

  • Chapter
  • First Online:
Abdomen and Thoracic Imaging

Abstract

Computed tomography (CT) is essential for the diagnosis of liver tumors. In the CT criteria of hypervascular hepatocellular carcinoma (HCC), the diagnosis is based on hemodynamic findings, such as arterial enhancement, followed by washout in the portal-venous and/or equilibrium phase. In this chapter, typical and atypical findings (HCC mimickers) of HCC on CT and current diagnostic techniques to image HCC were stated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bosch FX, Ribes J, Diaz M, Cleries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5 Suppl 1):S5–S16

    Article  PubMed  Google Scholar 

  2. Marrero JA, Welling T (2009) Modern diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 13:233–247

    Article  PubMed  Google Scholar 

  3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  4. El-Serag HB, Tran T, Everhart JE (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126:460–468

    Article  PubMed  Google Scholar 

  5. Chen CJ, Yu MW, Liaw YF (1997) Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12:S294–S308

    Article  PubMed  CAS  Google Scholar 

  6. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS (2002) NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36:1349–1354

    PubMed  Google Scholar 

  7. Matsui O (2004) Imaging of multistep human hepatocarcinogenesis by CT during intra-arterial contrast injection. Intervirology 47:271–276

    Article  PubMed  Google Scholar 

  8. Hayashi M, Matsui O, Ueda K et al (1999) Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. AJR Am J Roentgenol 172:969–976

    Article  PubMed  CAS  Google Scholar 

  9. Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB (2008) Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics 28:747–769

    Article  PubMed  Google Scholar 

  10. Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN, Theise ND (1998) Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol 22:656–662

    Article  PubMed  CAS  Google Scholar 

  11. Roncalli M, Roz E, Coggi G et al (1999) The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 30:1174–1178

    Article  PubMed  CAS  Google Scholar 

  12. Murakami T, Onishi H, Mikami K et al (2006) Determining the optimal timing for early arterial phase hepatic CT imaging by measuring abdominal aortic enhancement in variable contrast injection protocols. J Comput Assist Tomogr 30:206–211

    Article  PubMed  Google Scholar 

  13. Noguchi Y, Murakami T, Kim T et al (2003) Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT. AJR Am J Roentgenol 180:455–460

    Article  PubMed  Google Scholar 

  14. Walkey MM (1991) Dynamic hepatic CT: how many years will it take ‘til we learn? Radiology 181:17–18

    PubMed  CAS  Google Scholar 

  15. Brink JA, Heiken JP, Forman HP, Sagel SS, Molina PL, Brown PC (1995) Hepatic spiral CT: reduction of dose of intravenous contrast material. Radiology 197:83–88

    PubMed  CAS  Google Scholar 

  16. Heiken JP, Brink JA, McClennan BL, Sagel SS, Crowe TM, Gaines MV (1995) Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology 195:353–357

    PubMed  CAS  Google Scholar 

  17. Takahashi S, Murakami T, Takamura M et al (2002) Multi-detector row helical CT angiography of hepatic vessels: depiction with dual-arterial phase acquisition during single breath hold. Radiology 222:81–88

    Article  PubMed  Google Scholar 

  18. Tada S, Fukud K, Aoyagi Y, Harada J (1980) CT of abdominal malignancies: dynamic approach. AJR Am J Roentgenol 135:455–461

    Article  PubMed  CAS  Google Scholar 

  19. Young SW, Turner RJ, Castellino RA (1980) A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics. Radiology 137:137–147

    PubMed  CAS  Google Scholar 

  20. Araki T, Itai Y, Furui S, Tasaka A (1980) Dynamic CT densitometry of hepatic tumors. AJR Am J Roentgenol 135:1037–1043

    Article  PubMed  CAS  Google Scholar 

  21. Dean PB, Violante MR, Mahoney JA (1980) Hepatic CT contrast enhancement: effect of dose, duration of infusion, and time elapsed following infusion. Invest Radiol 15:158–161

    Article  PubMed  CAS  Google Scholar 

  22. Berland LL, Lee JY (1988) Comparison of contrast media injection rates and volumes for hepatic dynamic incremented computed tomography. Invest Radiol 23:918–922

    Article  PubMed  CAS  Google Scholar 

  23. Claussen CD, Banzer D, Pfretzschner C, Kalender WA, Schorner W (1984) Bolus geometry and dynamics after intravenous contrast medium injection. Radiology 153:365–368

    PubMed  CAS  Google Scholar 

  24. Yagyu Y, Awai K, Inoue M et al (2005) MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations. Am J Roentgenol 184:1535–1540

    Article  Google Scholar 

  25. Kormano M, Partanen K, Soimakallio S, Kivimaki T (1983) Dynamic contrast enhancement of the upper abdomen: effect of contrast medium and body weight. Invest Radiol 18:364–367

    Article  PubMed  CAS  Google Scholar 

  26. Awai K, Inoue M, Yagyu Y et al (2004) Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology 233:682–688

    Article  PubMed  Google Scholar 

  27. Han JK, Kim AY, Lee KY et al (2000) Factors influencing vascular and hepatic enhancement at CT: experimental study on injection protocol using a canine model. J Comput Assist Tomogr 24:400–406

    Article  PubMed  CAS  Google Scholar 

  28. Ichikawa T, Erturk SM, Araki T (2006) Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients’ body-weight-tailored dose of contrast material. Eur J Radiol 58:165–176

    Article  PubMed  Google Scholar 

  29. Tomemori T, Yamakado K, Nakatsuka A, Sakuma H, Matsumura K, Takeda K (2001) Fast 3D dynamic MR imaging of the liver with MR SmartPrep: comparison with helical CT in detecting hypervascular hepatocellular carcinoma. Clin Imaging 25:355–361

    Article  PubMed  CAS  Google Scholar 

  30. Kanematsu M, Goshima S, Kondo H et al (2005) Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 29:195–201

    Article  PubMed  Google Scholar 

  31. Awai K, Hiraishi K, Hori S (2004) Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. Radiology 230:142–150

    Article  PubMed  Google Scholar 

  32. Awai K, Hori S (2003) Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 13:2155–2160

    Article  PubMed  Google Scholar 

  33. Kondo H, Kanematsu M, Goshima S et al (2008) Abdominal multidetector CT in patients with varying body fat percentages: estimation of optimal contrast material dose. Radiology 249:872–877

    Article  PubMed  Google Scholar 

  34. Erturk SM, Ichikawa T, Sou H, Tsukamoto T, Motosugi U, Araki T (2008) Effect of duration of contrast material injection on peak enhancement times and values of the aorta, main portal vein, and liver at dynamic MDCT with the dose of contrast medium tailored to patient weight. Clin Radiol 63:263–271

    Article  PubMed  CAS  Google Scholar 

  35. Yamashita Y, Komohara Y, Takahashi M et al (2000) Abdominal helical CT: evaluation of optimal doses of intravenous contrast material—a prospective randomized study. Radiology 216:718–723

    Article  PubMed  CAS  Google Scholar 

  36. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  PubMed  Google Scholar 

  37. Brancatelli G, Federle MP, Ambrosini R et al (2007) Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 61:57–69

    Article  PubMed  Google Scholar 

  38. Krinsky GA, Lee VS (2000) MR imaging of cirrhotic nodules. Abdom Imaging 25:471–482

    Article  PubMed  CAS  Google Scholar 

  39. Baron RL, Peterson MS (2001) From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. Radiographics 21(Spec No(32)):S117–S132

    Article  PubMed  Google Scholar 

  40. Lim JH, Cho JM, Kim EY, Park CK (2000) Dysplastic nodules in liver cirrhosis: evaluation of hemodynamics with CT during arterial portography and CT hepatic arteriography. Radiology 214:869–874

    Article  PubMed  CAS  Google Scholar 

  41. Lim JH, Kim MJ, Park CK, Kang SS, Lee WJ, Lim HK (2004) Dysplastic nodules in liver cirrhosis: detection with triple phase helical dynamic CT. Br J Radiol 77:911–916

    Article  PubMed  CAS  Google Scholar 

  42. Park YN, Kojiro M, Di Tommaso L et al (2007) Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 109:915–923

    Article  PubMed  Google Scholar 

  43. Okazaki I, Wada N, Nakano M et al (1997) Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas. Hepatology 25:580–584

    Article  PubMed  CAS  Google Scholar 

  44. Llovet JM, Schwartz M, Mazzaferro V (2005) Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25:181–200

    Article  PubMed  Google Scholar 

  45. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917

    Article  PubMed  Google Scholar 

  46. International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658–664

    Google Scholar 

  47. Kim MJ, Choi JY, Chung YE, Choi SY (2008) Magnetic resonance imaging of hepatocellular carcinoma using contrast media. Oncology 75(Suppl 1):72–82

    Article  PubMed  CAS  Google Scholar 

  48. Imai Y, Murakami T, Yoshida S et al (2000) Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32:205–212

    Article  PubMed  CAS  Google Scholar 

  49. Sugihara S, Nakashima O, Kojiro M, Majima Y, Tanaka M, Tanikawa K (1992) The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound-guided fine-needle biopsy with those of autopsy. Cancer 70:1488–1492

    Article  PubMed  CAS  Google Scholar 

  50. Choi BI, Kim CW, Han MC et al (1989) Sonographic characteristics of small hepatocellular carcinoma. Gastrointest Radiol 14:255–261

    Article  PubMed  CAS  Google Scholar 

  51. Onishi H, Kim T, Imai Y et al (2012) Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT. Eur Radiol 845–854

    Google Scholar 

  52. Stevens WR, Gulino SP, Batts KP, Stephens DH, Johnson CD (1996) Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J Comput Assist Tomogr 20:337–342

    Article  PubMed  CAS  Google Scholar 

  53. Jonas S, Bechstein WO, Steinmuller T et al (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33:1080–1086

    Article  PubMed  CAS  Google Scholar 

  54. Todo S, Furukawa H (2004) Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 240:451–459

    Article  PubMed  Google Scholar 

  55. Quaglia A, Tibballs J, Grasso A et al (2003) Focal nodular hyperplasia-like areas in cirrhosis. Histopathology 42:14–21

    Article  PubMed  CAS  Google Scholar 

  56. Cuenod C, Leconte I, Siauve N et al (2001) Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 218:556–561

    Article  PubMed  CAS  Google Scholar 

  57. Hashimoto K, Murakami T, Dono K et al (2007) Quantitative tissue blood flow measurement of the liver parenchyma: comparison between xenon CT and perfusion CT. Dig Dis Sci 52:943–949

    Article  PubMed  Google Scholar 

  58. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY (1999) Dynamic CT measurement of cerebral blood flow: a validation study. Am J Neuroradiol 20:63–73

    PubMed  CAS  Google Scholar 

  59. Sahani DV, Holalkere NS, Mueller PR, Zhu AX (2007) Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue—initial experience. Radiology 243:736–743

    Article  PubMed  Google Scholar 

  60. Ma SH, Le HB, Jia BH et al (2008) Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression. BMC Cancer 8:186

    Article  PubMed  Google Scholar 

  61. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–390

    Article  PubMed  CAS  Google Scholar 

  62. Ippolito D, Sironi S, Pozzi M et al (2008) Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Acad Radiol 15:919–927

    Article  PubMed  Google Scholar 

  63. Yanagawa M, Tomiyama N, Honda O et al (2010) Multidetector CT of the lung: image quality with garnet-based detectors. Radiology 255:944–954

    Article  PubMed  Google Scholar 

  64. Okada M, Kim T, Murakami T (2011) Hepatocellular nodules in liver cirrhosis: state of the art CT evaluation (perfusion CT/volume helical shuttle scan/dual-energy CT, etc.). Abdom Imaging 36:273–281

    Article  PubMed  Google Scholar 

  65. Schindera ST, Nelson RC, Mukundan S Jr et al (2008) Hypervascular liver tumors: low tube voltage, high tube current multi-detector row CT for enhanced detection—phantom study. Radiology 246:125–132

    Article  PubMed  Google Scholar 

  66. Graser A, Johnson TR, Bader M et al (2008) Dual energy CT characterization of urinary calculi: initial in vitro and clinical experience. Invest Radiol 43:112–119

    Article  PubMed  Google Scholar 

  67. Grosjean R, Sauer B, Guerra RM et al (2008) Characterization of human renal stones with MDCT: advantage of dual energy and limitations due to respiratory motion. Am J Roentgenol 190:720–728

    Article  Google Scholar 

  68. Scheffel H, Stolzmann P, Frauenfelder T et al (2007) Dual-energy contrast-enhanced computed tomography for the detection of urinary stone disease. Invest Radiol 42:823–829

    Article  PubMed  Google Scholar 

  69. Primak AN, Fletcher JG, Vrtiska TJ et al (2007) Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol 14:1441–1447

    Article  PubMed  Google Scholar 

  70. Goldberg HI, Cann CE, Moss AA, Ohto M, Brito A, Federle M (1982) Noninvasive quantitation of liver iron in dogs with hemochromatosis using dual-energy CT scanning. Invest Radiol 17:375–380

    Article  PubMed  CAS  Google Scholar 

  71. Johnson TR, Krauss B, Sedlmair M et al (2007) Material differentiation by dual energy CT: initial experience. Eur Radiol 17:1510–1517

    Article  PubMed  Google Scholar 

  72. Brooks RA (1977) A quantitative theory of the Hounsfield unit and its application to dual energy scanning. J Comput Assist Tomogr 1:487–493

    Article  PubMed  CAS  Google Scholar 

  73. Nakayama Y, Awai K, Funama Y et al (2005) Abdominal CT with low tube voltage: preliminary observations about radiation dose, contrast enhancement, image quality, and noise. Radiology 237:945–951

    Article  PubMed  Google Scholar 

  74. Yeh BM, Shepherd JA, Wang ZJ, Teh HS, Hartman RP, Prevrhal S (2009) Dual-energy and low-kVp CT in the abdomen. Am J Roentgenol 193:47–54

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masahiro Okada M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Okada, M., Murakami, T. (2014). CT Imaging Characteristics of Hepatocellular Carcinoma. In: El-Baz, A., Saba, L., Suri, J. (eds) Abdomen and Thoracic Imaging. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-8498-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8498-1_12

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-8497-4

  • Online ISBN: 978-1-4614-8498-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics